Are you ready for January 1st, 2026? The 340B Rebate Pilot will shift 340B reimbursement from an upfront discount to an after-fact rebate. Let Tungsten+PLUS™ platform manage the rebate model’s multiple manufacturer vendor systems for you.
PCAs, major 340B gateways, CEs and major hospital systems are actively participating. Manufacturers are already leveraging the system, and its seamless integration into their operations is driving a strong upward trajectory in participation. Learn More >
RxParadigm is a pharmacy technology solutions company founded by experts in drug-pricing transparency, rebate administration, and 340B compliance. Powered by the Tungsten+PLUS™ platform and a centralized 340B Clearinghouse data management system, RxParadigm delivers transparency, compliance, and operational efficiency across the drug supply chain. The platform is purpose-built to support Medicare Maximum Fair Price (MFP) effectuation and the implementation of rebate-based models, while ensuring the integrity, transparency, and sustainability of the 340B program in an equitable manner for all stakeholders. Tungsten+PLUS™ eliminates duplicate payments, enables efficient and auditable dispute resolution, preserves patient access, and safeguards overall program integrity.
This post is related to:
